Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine plus ropivacaine versus ropivacaine alone for postoperative ankle block after foot surgery
RBR-6yv2xryPhase 4Not yet recruiting
- Sponsor
- Prevent Senior
- Start
- Aug 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in bunion deformity (HAV) and hammertoe comparing Ropivacaine control with Ropivacaine + dexmedetomidine (2 arms). Primary endpoint: Postoperative pain relief. Planned start Aug 2021; status: not yet recruiting.
02
Drugs
dexmedetomidineropivacaine
03
Conditions
bunion deformity (HAV)hammertoe
Beyond the preview
Go deeper on RBR-6yv2xry.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-6yv2xry.